CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Marizyme Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Marizyme Inc
555 HERITAGE DRIVE, SUITE 205
Phone: (561) 935-9955p:561 935-9955 JUPITER, FL  33458  United States Ticker: MRZMMRZM
Business Summary
Marizyme, Inc. is a medical technology company. The Company is focused on cardiac and surgical care by delivering innovative solutions for coronary artery bypass graft (CABG) surgery and other surgical procedures. Its product DuraGraft, is a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, thereby reducing the incidence and complications of graft failure and improving clinical outcomes post bypass surgery. The Company’s product under development includes MATLOC and MAR-FG-001. MATLOC is a lab-on-chip digital screening and diagnostic device platform being developed for quantitative chronic kidney disease (CKD) assessment. The MAR-FG-001 is a tumescent solution base for fat grafting procedures that is used for plastic and cosmetic surgeries in which fat is transferred from one area of the body to another to correct a defect, replace injured tissue, or to make cosmetic enhancements.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
5020 Furniture and homefurnishings

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Vithalbhai D.Dhaduk 69 11/16/2021 2/22/2021
Chief Executive Officer, Secretary, Director DavidBarthel 65 10/1/2022 11/10/2021
Chief Financial Officer, Treasurer GeorgeKovalyov 39 12/1/2021 12/1/2021
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
GBS Software AG Am Storrenacker 1a KARLSRUHE Germany
Somahlution, Inc. 225 Chimney Corner Lane Jupiter FL United States

Business Names
Business Name
GBS Enterprises Inc
GBSX
GBSXD
11 additional Business Names available in full report.

General Information
Number of Employees: 11 (As of 5/13/2024)
Outstanding Shares: 131,793,088 (As of 6/30/2024)
Shareholders: 401
Stock Exchange: OTC
Federal Tax Id: 273755055
Fax Number: (770) 720-1335


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024